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ABSTRACT 
The endothelium from different vascular beds exhibits a high degree of 
phenotypic heterogeneity.  Endothelial cells (EC) can be easily harvested from 
large vessels by mechanical removal or collagenase digestion.  In particular, the 
human umbilical vein has been used due to its wide availability, and the study of 
ECs derived from it has undoubtedly greatly advanced our knowledge of vascular 
biology.  However, the majority of the body’s endothelium (>95%) forms the 
microvasculature and it is these cells providing the interface between the blood 
and tissues that play a critical role in the development of new blood vessels. This 
has led to the establishment of techniques for the isolation of microvascular ECs 
(MEC) from different tissues to provide more physiologically relevant in vitro 
models of angiogenesis and EC function.    
 
In this chapter the use of superparamagnetic beads (Dynabeads) coated with  
anti-PECAM-1 (CD31) antibodies (‘PECA-beads’) to culture MECs from human 
adipose tissue is described along with the standard methods used to   
characterise them.  Adipose tissue is an ideal source of MECs as it is composed 
mainly of adipocytes with a very rich microvasculature, and is easy to 
disaggregate. Furthermore, it and can be obtained in large quantities during 
plastic surgery procedures.  Adipose obtained at reduction mammoplasty or 
abdominoplasty is first dissected free of connective tissue, minced finely and 
subjected to collagenase type-II digestion.  The adipocytes are removed by 
centrifugation to obtain a microvessel rich pellet, which is further disaggregated 
with trypsin/EDTA solution.  Following filtration to remove fragments of 
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connective tissue the pellet is incubated with PECA-beads and microvessel 
fragments/ECs washed and harvested using a magnet.  In addition, the 
adaptation of this basic technique for the isolation of human lung and stomach 
MECs is also described along with common methods for the preparation of large 
vessel endothelial cells.   
 
 
Key words:  endothelial cells, microvascular, adipose, Dynabeads, PECAM-
1/CD31, von Willebrand Factor, E-selectin. 
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1. Introduction  
 
 Human ECs derived from large vessels including the aorta, and umbilical (1) and 
saphenous veins have proven an abundant and convenient tool for the 
investigation of many aspects of endothelial biology.  However, the endothelium 
demonstrates a high degree of functional, morphological, biochemical and 
molecular diversity between organs, and within the different vascular beds of a 
given organ (2-6).  This phenotypic heterogeneity has highlighted the need for 
reliable techniques for MEC isolation and culture from a variety of tissues in order 
to establish more realistic in vitro models.  
 
Many techniques have been developed to enrich ECs from tissue homogenates, 
either directly or after a period in culture (6).  Most methods use as their starting 
point tissue homogenisation and digestion and are often hampered by low EC 
yield and problems of contaminating cell populations that readily adapt to culture.  
Some tissues are inherently better suited to MEC isolation such as brain and 
adipose, which have high microvascular densities, and can be disaggregated 
easily (2, 6-9).  Wagner and Matthews (7) were the first to utilise adipose tissue 
from the rat epididymal fat pad for the isolation of microvascular endothelium. 
The major advantage of this tissue is the difference in buoyant densities between 
the adipocytes and stromal component allowing their separation by 
centrifugation.   
 
The development of superparamagnetic beads (Dynabeads) coupled to 
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endothelial-specific ligands represented a major advance in the purification of 
MECs from mixed cell populations.  The original technique described by Jackson 
and colleagues (10) employed the lectin Ulex europaeus agglutinin-1 (UEA-1), 
which binds specifically to α-fucosyl residues of EC glycoproteins.  However, 
UEA-1 also binds to some epithelial and mesothelial cells (1,11).  We refined this 
technique by coupling antibodies raised against platelet EC adhesion molecule-1 
(PECAM-1/CD31) (12), a pan-endothelial marker (3,4), to Dynabeads (‘PECA-
beads’), and have used these to prepare MECs from various human tissues 
(13,14).  Similarly, other endothelial markers, including CD34 have been used to 
isolate MECs.  However, the majority of EC markers, including PECAM-1 and 
CD34 cross-react with subpopulations of haematopoietic cells which share 
common developmental origins.  However, haematopoietic cells do not usually 
represent a significant problem for MEC isolation due to their limited viability in 
culture.  Mesothelial cells exhibit similar morphology and share common markers 
with ECs and so represent a potentially difficult contaminant of EC cultures 
isolated from tissues surrounded by a serosal layer, such as omentum and lung. 
(6,11).  However, the absence of constitutive PECAM-1 expression in these cells 
means that use of PECA-bead selection should eliminate mesothelial cell 
contamination of endothelial isolates (11).   
 
In this chapter we describe in detail the use of PECA-beads to isolate MECs from 
human adipose tissue and methods for the routine culture of these cells.  In 
addition, the adaptation of this purification technique for the culture of MECs from 
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human lung and stomach (13,14) is provided alongside routine methods for the 
preparation of large vessel endothelial cells from the umbilical vein and aorta.   
 
2. Materials 
 
2.1.  Solutions for MEC isolation and culture 
All solutions should be warmed to 37°C prior to use. 
1. 10% BSA solution: Dissolve 10 g of bovine serum albumin (BSA) in 100 ml 
of calcium-magnesium free Dulbecco’s phosphate buffered saline 
(PBS/A), 0.22 µm filter sterilise and store at 4oC.  
 
2. Antibiotic/antimycotic solution: Dilute 100x antibiotic/antimycotic solution 
(Sigma) in PBS/A to give final concentration of 100 U/ml Penicillin, 0.1 
mg/ml Streptomycin and 0.25 µg/ml Amphotericin B.  Aliquot and store the 
100x stock solution at -20°C.  
3. Collagenase solution: Dissolve type-II collagenase (Sigma) at 2000 U/ml 
in Hank’s balanced salt solution (HBSS) containing 0.5 % (w/v) BSA, 0.22 
µm filter sterilise, aliquot and store at -20oC.  
4. Trypsin/EDTA solution: Dilute 10x stock solution of porcine trypsin (2.5%) 
in PBS/A, and add 1 mM (0.372 g/L) ethylenediaminetetraacetic acid 
(EDTA).  0.22 µm filter sterilise, aliquot and store at -20°C. 
  
5. Gelatin solution: Dilute stock (2%) porcine gelatin solution in PBS/A to give 
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a 0.2% (v/v) solution and store at 4oC. To coat tissue culture dishes add 
0.2% gelatin solution and incubate for 1 h at 37oC or overnight at 4oC.  
Remove the gelatin solution from the flasks immediately prior to plating the 
cells.  
 
6. Growth medium:  Many different growth media have been described for 
maintaining EC in culture (see Note 1).  Supplement M199 (with Earle’s 
salts) with 14 ml/l of 1 M N-[2-hydroxyethyl] piperazine-N’-[2-hydroxy-
propane] sulphonic acid (HEPES) solution, 20 ml/L of 7.5% sodium 
hydrogen carbonate solution, 20 ml/L 200 mM L-glutamine solution and 
mix 1:1 with Ham F12 nutrient mix.  To 680 ml of medium M199/Ham F12 
solution add 20 ml of Penicillin (100 U/ml) / Streptomycin (100 µg/ml) 
solution, 1500 U/L of heparin, 300 ml of iron-supplemented calf serum 
(CS) (see Note 2), 1 µg/ml hydrocortisone, 5 ng/ml basic fibroblast 
growth factor (bFGF/FGF-2) and 20 ng/ml epithelial growth factor (EGF) 
(PeproTech EC Ltd, London, UK) (see Note 3).  Store growth medium at 
4oC.   
 
7. Cryopreservation Medium:  Growth medium containing 10% (v/v) tissue 
culture grade dimethyl sulphoxide.  
 
8. Dispase solution: Dissolve 2/U ml dispase in Medium M199 containing 
20% CS, 0.22 µm filter sterilise, aliquot and store at -20°C.  Note: This is 
only required for the isolation of human lung MEC. 
 7 
   
2.2. Preparation of PECA beads. 
Mix 0.1-0.2 mg of mouse anti-PECAM-1 monoclonal antibody (e.g. clone 9G11 
R&D Systems) in sterile PBS/A containing 0.1% BSA (PBS/A+0.1% BSA) per 10 
mg of Dynabeads-M450 (Invitrogen Dynal AS - see Note 4) pre-coated with pan 
anti-mouse IgG2 (see Note 5).  Incubate on a rotary stirrer for 16 h at 4oC. 
Remove free antibody by washing four times for 10 min, and then overnight in 
PBS/A+0.1% BSA.  PECA-beads maintain their activity for more than 6 months if 
sterile and stored at 4°C.  However, it is necessary to wash the beads with 
PBS/A + 0.1% BSA to remove any free antibody prior to use. 
 
2.3. Equipment for EC isolation 
A class II laminar flow cabinet is essential for all procedures involving the 
handling of tissue and cultured cells to maintain sterility and protect the operator.   
Scalpels, scissors and forceps are required for the isolation procedures and 
should be sterilised by autoclaving at 121oC for 30 min.   
 
100 µm nylon filters: Cover the top of a polypropylene funnel ~ 10 cm with 100 
µm nylon mesh and sterilise by autoclaving (see Note 6).    
 
Magnet: A suitable magnet is required for the magnetic cell selection system 
employed which accepts 15 ml tubes (see Note 7).   
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Disposable sterile plastics 
1. 25 and 75 cm2 tissue culture flasks  
2. Large plastic dishes (e.g. Bioassay dishes, Nunc, Naperville, IL, USA) 
3. 30 ml universal tubes  
4. 50 ml centrifuge tubes  
5. Lab-Tek multiwell glass chamber slides (Nunc, Naperville, IL, USA)  
6. 20 ml luer-lock syringes. 
7. luer-lock three-way stopcocks  
 
2.4. Antibodies for EC characterisation  
There are many commercial antibodies available against endothelial markers.  
1. Monoclonal antibodies against human PECAM-1, E-selectin and vWF (e.g. 
clone F8/86; Dako, High Wycombe, Bucks, UK).  
2. Fluorescein isothiocyanate (FITC)-conjugated anti-mouse secondary 
antibodies. 
3. Nuclear counterstain:  Dissolve Hoescht 33342 (Sigma) in PBS/A 10 µg/ml 
to give a 10 µg/ml solution, aliquot and store at -20°C.  
 
3. Methods 
 
3.1. Isolation and culture of human adipose MECs  
 
3.1.1.  Collection of tissue  
A suitable large sterile container is required for the collection of adipose tissue 
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obtained during breast or abdominal reductive surgery (see Note 8). The fat can 
be processed immediately or stored for up to 48 h at 4oC.  
 
3.1.2.  Isolation of adipose MECs  
 
1. Working under sterile conditions in a class II cabinet, place the tissue on a 
large sterile dish (e.g. Bioassay dish, Nunc) and wash with 2% 
antibiotic/antimycotic solution.  Avoiding areas of dense (white) connective 
tissue (that are often prevalent in breast tissue) and visible blood vessels, 
scrape the fat free from the connective tissue with two scalpel blades.   
 
2. Chop the fat up finely and aliquot 10-20 g into sterile 50 ml centrifuge 
tubes.  Add 10 ml of PBS/A, and 5-10 ml of the type-II collagenase 
solution. Shake the tubes vigorously to further break up the fat and 
incubate with end-over-end mixing on a rotary stirrer at 37oC for 
approximately 1 h.  Following digestion the fat should have broken down 
and no spicules should be evident.    
 
3. Centrifuge the digests at 500 g for 5 min, discard the fatty (top) layer and 
retain the cell pellet with some of the lower (aqueous) layer. Add PBS/A, 
and re-centrifuge 500 g for 5 min.  
 
4. Re-suspend the cell pellet in 10% BSA solution and centrifuge (200 g, 10 
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min).  Discard the supernatant and repeat the centrifugation in 10% BSA 
solution. Wash the pellet with 50 ml of PBS/A.  Viewed under the light 
microscope the tissue digest should contain obvious microvessel 
fragments in addition to single cells and debris.   
 
5 Re-suspend the pellet obtained in 5 ml of trypsin/EDTA solution and 
incubate for 10-15 min with occasional agitation at 37oC. Add 20 ml HBSS 
containing 5% CS (HBSS+5%CS) and mix thoroughly to neutralise the 
trypsin.  We have found it advantageous to break up the microvessel 
fragments and cell clumps further with trypsin/EDTA as this reduces the 
number of contaminating cells co-isolated with the ECs during PECA-bead 
purification.   
 
6. Filter the suspension through 100 µm nylon mesh to remove fragments of 
sticky connective tissue.  Centrifuge the filtrate at 700 g, for 5 min and re-
suspend the resulting pellet in ~1-2 ml of ice-cold HBSS+5%CS.   
 
7. Add approximately 50 µl of PECA-beads and incubate for ~20 min at 4oC 
with occasional agitation (see Note 9).  Add HBSS+5%CS to a final 
volume of ~12 ml, mix thoroughly, and select the microvessel fragments / 
ECs using a suitable magnet (see Note 7) for 3 min.  Repeat the cell 
selection process a further 3-5 times by washing the magnetically 
separated material in ~12 ml of HBSS+5%CS and reselecting the 
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microvessel fragments with the magnet.  
 
8. Suspend the magnetically separated cells in growth medium (see Note 
10) and seed at high density onto 0.2% gelatin-coated 25 cm2 tissue 
culture flasks and incubated at 37oC in a humidified atmosphere of 5% 
CO2.  
 
3.1.3. Adipose MECs in culture 
Following the PECA-bead selection procedure small microvessel fragments and 
single cells coated with Dynabeads should be evident under light microscopy 
(see Note 11).  After 24 h the cells adhere to the flasks and start to grow out from 
the microvessel fragments present to form distinct colonies.  Human mammary 
microvessel EC (HuMMEC) isolated using this technique grow to confluence 
forming contact-inhibited cobblestone-like monolayers within 10-14 days 
depending on the initial seeding density.  We have successfully cultured these 
cells to passage 8 without observable change in their morphology, but routinely 
use them in experiments between passages 3 to 6.   
 
3.1.4. Subculture of adipose MEC  
Maintain the MECs at 37oC, 5% CO2 changing the medium every 3-4 days.  When 
confluent EC can be passaged using trypsin/EDTA solution, onto 0.2% gelatin-
coated dishes at a split ratio of 1:4 as follows.  
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1. Discard the old medium and wash the cell monolayer twice with 5-10 ml of 
PBS/A. Add a few ml of trypsin/EDTA solution, wash it over the cell 
monolayer, remove the surplus leaving the cells just covered and incubate 
at 37oC for 1-2 min.  Monitor the cells regularly under the microscope until 
they round up and detach (see Note 12).  Striking the flask sharply helps to 
dislodge the cells and break up cell aggregates.  
 
2. Add sufficient growth medium to achieve a split ratio of ~1:4 and plate the 
cells onto gelatin-coated flasks.  
 
3.1.5. Microcarrier beads  
Microcarrier beads can be used to continuously culture EC without the need to use 
trypsin.  Following hydration and sterilisation according to the manufacturer’s 
instructions add the gelatin-coated Cytodex 3 microcarrier beads (Sigma) to the 
medium and allow the EC to crawl onto and attach to the microcarriers.  Agitate 
the flasks occasionally to facilitate seeding carriers over a period of 2-3 days.  
Remove the beads and place into a fresh gelatin-coated flasks containing growth 
medium and allow the cells to attach to the flask agitating occasionally to ensure 
good distribution of the cells.  Once sufficient cells have attached the beads may 
be removed and placed into a fresh flask and the process is repeated.   
    
3.1.6.  Cryopreservation of EC: Following trypsinization (see Subheading 3.1.4.) 
Suspend ECs at ~ 2x106/ml in the cryopreservation medium and dispense into 
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suitable cryovials.  Cool the vials to -80°C at 1oC/min and store under liquid 
nitrogen.  
 
3.1.7. Maintaining the purity of MEC cultures 
It may be necessary to reselect the ECs with PECA-beads and/or perform minor 
manual `weeding' to maintain the purity of cultures.  Reselection with PECA-
beads can be performed as described above (see Subheading 3.1.2. Item 7) 
following removal of the cells from flasks using trypsin/EDTA solution (see 
Section 3.1.4.).  Provided that there are clear morphological differences between 
contaminating cell populations and the ECs (see Note 13) it is relatively 
straightforward, although time consuming, to physically remove them. Manual 
weeding should be performed with the stage of a phase contrast microscope 
within a class II cabinet to ensure sterile conditions.  A needle or Pasteur pipette 
is used to carefully remove contaminating cells from around EC colonies. The 
medium is discarded and the adherent cells washed with several changes of 
sterile PBS/A to remove the dislodged contaminating cells. 
 
3.2. Characterisation of ECs  
 
3.2.1. EC morphology in culture 
Cobblestone morphology is very typical of ECs derived from many tissues and 
they are usually readily distinguished from the typical fibroblastoid contaminating 
cell populations. However, a more elongated morphology has been reported for 
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human MEC derived from some tissues, and similar elongated phenotypes 
forming ‘swirling’ monolayers are often observed following stimulation of ECs with 
growth factors.  EC will form “capillary-like” tube networks within few hours of 
plating on matrices such as growth factor-reduced Matrigel.  This phenomenon 
also occurs in many types of MECs if cultures are left for several days at 
confluence (Figure 1).  However, the formation of "capillary-like" structures is not 
an exclusive property of ECs in culture. 
 
3.2.2.  Key EC markers 
There are many criteria on which EC identification may be based which have 
been reviewed extensively (see 2-4,6).  Many endothelial markers/properties are 
not unique to ECs and several may be required to confirm endothelial identity.  
ECs isolated from different vascular beds may also display phenotypic 
heterogeneity and lack of a particular marker may not preclude the endothelial 
origin of isolates (2).  It is often useful to demonstrate the absence of markers 
characteristic of potential contaminating cell populations such as smooth muscle 
α-actin positive stress fibres and the intermediate filament protein, desmin, which 
are expressed by smooth muscle cells and pericytes (15). 
   
A number of good endothelial markers have been identified, including endothelial 
cell adhesion molecule (ICAM-2 / CD102), endothelial cell-selective adhesion 
molecule (ESAM) and vascular endothelial cadherin (VE cadherin) (4).  Here we 
focus on von Willebrand Factor (vWF), PECAM-1 (12), and E-selectin 
 15 
(endothelial-leukocyte adhesion molecule-1 / CD62E) (16) that we believe to be 
useful for the rapid identification of ECs.  
  
vWF is only expressed at significant levels in ECs, platelets, megakaryocytes, 
and the syncytiotrophoblast of the placenta.  In ECs it is stored in the rod-shaped 
Weibel-Palade bodies, which produce characteristic punctate perinuclear 
staining. These organelles are present in large vessel EC but have been reported 
to be scarce or absent in the capillary endothelium of various species (1-4,6).  
However, typical granular perinuclear staining for vWF has been reported in 
cultured human kidney, dermis (10), synovium, lung (13), stomach (14), decidua, 
heart, adipose  (9,13) and brain (8) MECs. 
 
PECAM-1 is constitutively expressed on the surface of ECs (>106 molecules/cell), 
and to a lesser extent in platelets, granulocytes and a subpopulation of CD8+ 
lymphocytes (6,12). PECAM-1 staining of ECs in vitro is characterised by typical 
intense membrane fluorescence at points of cell-cell contact (see Figure 2).  
 
E-selectin: Strong expression of E-selectin following stimulation with pro-
inflammatory cytokines appears to be a unique characteristic of ECs (13).  It is 
not expressed constitutively by the majority of ECs, but stimulation with tumour 
necrosis factor-α (TNFα), or interleukin-1β (IL-1β) leads to intense E-selectin 
staining of the EC plasma membrane reaching a maximum after 4-8 hours (see 
Figure 3).    
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3.2.3. Immunocytofluoresent characterisation of ECs 
 
 
Outlined below is a simple protocol for the immunofluorescent detection of EC 
markers. 
1. Preparation of ECs on glass slides.  Multiwell glass chamber slides are 
extremely useful for this purpose as multiple tests can be performed on 
the same slide conserving both reagents and cells. ECs are cultured on 
chamber slides that have been pre-treated for 1 h with 5 µg/cm2 bovine 
fibronectin (Sigma) in PBS/A or 0.2 % gelatin.  When sufficient cells are 
present discard the medium and wash twice with PBS/A prior to fixation.  
Different fixatives can be employed depending on the activity of the 
antibody used.  Acetone fixation is suitable for most antibodies:  Place the 
slides (see Note 14) in cold acetone (-20°C, 10 min), air dry and store 
frozen at -80°C.  Alternatively, fix cells in 3.7 % formaldehyde solution for 
30 min at room temperature.  Formaldehyde does not permeabilise the 
plasma membrane and further treatment with 0.1 % Nonidet P-40 or Triton 
X-100 is required to detect cytoplasmic / nuclear antigens. 
  
2. Immunocytoflourescent staining.  Warm up slides to room temperature 
and wash with PBS/A (2 x 5 min).  Block slides for 20 min with 10 % 
normal serum from the species in which the secondary antibody was 
raised to prevent non-specific binding of the secondary antibody.   
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3. Incubate slides with a predetermined or the manufacturer’s recommended 
concentration of primary antibody in PBS/A for 60 min at room 
temperature.   
 
4. Wash slides with PBS/A (3 x 5 min) and incubate with the appropriate 
FITC-labelled secondary antibody at 1:50 dilution in PBS/A for 30 min to 1 
h at room temperature and protect direct light. 
  
5. Counterstain cells with Hoescht 33342 (10 µg/ml) in PBS/A for 10 mins to 
facilitate assessment of EC purity.  
  
6. Wash slides in PBS/A (3 x 5 min), mount in 50 % (v/v) glycerol in PBS/A.  
Stained slides can be stored for several months in the dark at 4oC. 
 
Controls:  To avoid false positives generated by non-specific binding of 
secondary antibodies it is essential to include negative controls of cells treated as 
described above, but with an isotype-matched control antibody and/or PBS/A 
substituted for the primary antibody.  It is also useful to include as controls other 
cell types such as fibroblasts, smooth muscle cells and previously characterised 
ECs to act as negative and positive control cells respectively. 
 
E-selectin:  Cells are incubated with 1-10 ng/ml TNFα or IL-1β in growth medium 
for 4-6 h prior to fixation to induce E-selectin expression.  Unstimulated cells 
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should be used as controls. 
 
3.2.4. Other properties of human adipose MECs 
These cells possess typical EC characteristics including scavenger receptors for 
acetylated low-density lipoprotein, expression of the transforming growth factor-β 
co-receptor, endoglin (CD105), and high levels of angiotensin-converting enzyme 
activity.  All the EC types that we have cultured also express the vascular 
endothelial cell growth factor (VEGF) receptors Flt-1, Flt-4 and KDR/Flk-1 (15), 
and proliferate and express tissue factor in response to VEGF. Similarly, the 
angiopoietin receptor, Tie-2/Tek and Tie-1 and are also expressed by these cells.   
 
3.3. Isolation of MECs from other vascular beds  
We have adapted the basic method for the selection of adipose MECs to isolate 
ECs from other tissues.  Here we outline briefly the modifications that have been 
made for the isolation of human lung (12) and stomach MECs (18). 
 
3.3.1. MECs from human lung 
Although it has a high microvascular density, lung is composed of many diverse 
cell types that readily adapt to culture, and is generally more difficult to obtain 
than adipose tissue.  We have successfully isolated EC from normal lung from 
transplant donors and diseased tissue from transplant recipients (13). To ensure 
that MECs are harvested a thin strip of tissue at the periphery of the lung is used.  
As the amount of tissue available is usually limited, and we have found that the 
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yield of cells following direct Dynabead selection is low, it is better to allow the 
cells to proliferate in culture for a few days and then perform the magnetic 
purification with PECA-beads before they became overgrown with contaminating 
cells. 
 
1. Cut small peripheral sections of lung (3-5 cm long ~ 1 cm from the 
periphery) and wash in antibiotic/antimycotic solution.  
 
2. Dissect the underlying tissue from the pleura and chop it up very finely 
between scalpel blades, or by using a tissue chopper.  
 
3. Wash the minced tissue above sterile 20 µm nylon mesh (prepared as 
described under Subheading 2.3. - see Note 6) to filter out blood cells 
and fine debris.  
 
4. Incubate the retained material overnight in dispase solution on a rotary 
stirrer at 37oC overnight.  
 
5. Pellet the digest, resuspended in ~5 ml of trypsin/EDTA solution and 
incubate at 37oC for 15 min.  
 
6. Add growth medium and remove fragments of undigested tissue by 
filtration through 100 µm nylon mesh.   
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 7. Pellet and resuspended the cells in growth medium and plate onto gelatin-
coated dishes.  
 
8. Monitor the cultures daily, trypsinize and select the ECs using PECA-
beads before they became overgrown by contaminating cells (see 
Subheading 3.1.7.).    
     
3.3.2 Human stomach MECs 
MECs can be cultured from stomach mucosa obtained from biopsies or organ 
donors (14).  
 
1. Expose the stomach mucosa wash with antibioitic/antimycotic solution. 
 
2. Dissect the mucosa from the from the underlying muscle, chop into 2-3 mm 
pieces, and incubate in 1 mM EDTA in HBSS at 37oC in a shaking water bath 
for 30 min.  
 
3. Transfer the pieces of mucosa to collagenase type-II solution for 60 min, and 
then trypsin/EDTA solution for 15 min, in a shaking water bath at 37oC.  
 
4. Using a blunt dissecting tool scrape the mucosa and submucosa from white 
fibrous tissue. 
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5. Suspend the mucosal tissue in HBSS+20% CS and wash through 100 µm 
nylon mesh. 
  
6. Centrifuge the filtrate (700 g, 5 min) and re-suspend the pellet in ~12 ml of 
HBSS+5%CS.  Proceed with PECA-bead selection (see Subheading 3.1.2. 
- Item 7).   
 
3.4.   Human large vessel EC isolation 
 
3.4.1.  Preparation of HUVEC   
The umbilical vein provides an abundant source of large vessel EC, which have 
been used extensively due to the availability of this post-natally redundant tissue 
and ease with which pure HUVEC preparations can be obtained.  The procedure 
given below has been adapted from the method originally reported by Jaffe and 
colleagues (1). 
 
1. Collect umbilical cords in a suitable covered container and store at 4°C 
(see Note 15).  
 
2. Working over a large dish or tray to contain any spills, wash off any blood 
from the surface of the cord with antibiotic/antimycotic solution and inspect 
the cord very carefully for the presence of clamp marks and damaged 
areas, which must be avoided to prevent smooth muscle cell 
contamination. Cut a length (>20 cm) of cord free of clamp marks using 
cord scissors (see Note 16).   
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3. Cannulate the umbilical vein using a three-way disposable luer-lock stop-
cock and secure using ligature. The umbilical vein with its larger and 
thinner walls is relatively easy to distinguish from the two narrow umbilical 
arteries surrounded by smooth muscle. 
 
4. Attach a syringe to the stop-cock and wash the cord through gently with 
~30 ml of PBS/A until all the residual blood is removed. 
 
5. Perfuse the cord with ~5-10 ml of 0.1 % (v/v) type-I collagenase (e.g. CLS-
Collagenase, Worthington) solution in HBSS (prepared as described for 
type-II collagenase – see Subheading 2.1.) carefully displacing any 
residual air, and clamp off the free-end. 
 
6. Place the cord on a large plastic tray (e.g. Nunc bioassay dish) cover and 
place in a humidified incubator at 37°C for ~15 min. 
 
7. Gently massage the cord and collect the collagenase solution from the 
vein into a 30 ml universal tube.  Wash through with ~ 20 ml of HBSS+5% 
CS. Centrifuge at 200 g for 10 min and resuspend the pellet in growth 
medium (see Note 1) and plate cells onto gelatin-coated 25 cm2 flasks.  
Under the phase contrast microscope sheets of ECs in addition to many 
single cells, red blood cells and debris should be apparent.  
 
8. Allow cells to attach to the flask for at least 4 h, or overnight, and then 
wash the cells twice with PBS/A to remove non-adherent cells and debris.  
Add fresh growth medium and incubate the flask at 37°C, in a humidified 
5% CO2 incubator changing the medium every two-to-three days until the 
cells reach confluence.  Passage the cells at a one-to-three ratio as 
described above (see Subheading 3.1.4). HUVEC de-differentiate quite 
rapidly in culture and we do not routinely use them beyond passage 4. 
 
3.4.2.    Human aortic ECs 
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A relatively simple method for the isolation of human aortic ECs (HAEC) is 
outlined below as described previously (18). It is also possible to physically 
remove the EC by gently scraping of the luminal surface of the aorta rather using 
collagenase digestion (see Note 17). This method can be directly applied to 
isolate EC from the aortas of other large mammals. 
 
1. Wash sections of human thoracic aorta obtained at post-mortem are 
thoroughly in antibiotic/antimycotic solution.  
 
2. Cut the vessel open longitudinally to expose the surface of the luminal 
endothelium and lay flat on a sterile petri dish.  Add collagenase solution 
(see Note 17) over the exposed luminal surface, cover with lid, and 
incubate at 37°C for ~15 min. in a humidified incubator.   
 
 3.  Wash the surface of the aorta with ~ 5 ml of HBSS+5% CS, drain and 
collect into a 30 ml universal tube. Centrifuge at 200 g for 10 min, 
resuspend the cell pellet in ~ 5 ml of growth medium and plate onto 
gelatin-coated T25 flasks and incubate in a 37°C, in a humidified 5% CO2 
incubator. 
 
4. After 12-24 h discard the medium, wash twice with PBS/A (10 ml), and add 
fresh medium and subculture the cells as described above passaging with 
trypsin at confluence (see Subheading 3.1.4.).   
   
 
4. Notes 
 
1. Many different growth media have been described for the culture of ECs.  
Some MECs have very specific requirements such as the presence of 
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human serum, while large vessel ECs tend to be far less fastidious in their 
growth requirements. This medium M199/Ham F12 nutrient mix based 
recipe is relatively inexpensive and works well for a range of ECs, but 
researchers may wish to optimise their media further. MCDB 131 (19) 
containing the supplements described (Subheading 2.1. - Item 6) 
represents an excellent alternative and can be used with lower 
concentrations of serum. There are now also several commercial sources 
of optimised EC media that are based on MCDB 131.  For example 
EGM™-1/2 and EGM™-MV-2 from Lonza  (Lonza,  San Diego, CA, USA) 
and although more expensive, they are very convenient and provide 
reliable support. 
  
2. Iron-supplemented bovine calf serum (CS) provides an economical 
alternative to FBS and in our hands supports the proliferation and survival 
of the EC well (see Note 1).  However, it is necessary to batch test all 
bovine sera to ensure optimal growth of ECs – some MECs such as those 
isolated from decidualized endometrium are reported to require the 
presence of human serum or specific growth factors such as VEGF (20).  
 
3. We use recombinant FGF-2 and EGF routinely, but VEGF (5-10 ng/ml) 
can also be added and provides excellent support for the majority of 
cultured EC, but is more expensive. These growth factors may also be 
substituted with EC growth supplement (ECGS) derived from bovine 
brain, which is rich in acidic and basic FGF and can be obtained from 
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various suppliers. 
 
4. There are alternatives to the use of Dynabeads, for example the Miltenyi 
Biotech MACS system. These use composite iron oxide and 
polysaccharide beads (50 nm diameter) and require a MACS separation 
system comprising a disposable filtration column which is placed in a 
magnetic field.  They offer the advantage that they are small and so do 
not interfere with cell attachment and subsequent use of the cells in 
procedures such as flow cytometry. 
 
5. Precoated Dynabeads (and CELLelection beads - see Note 10) carrying 
various secondary antibodies (e.g. pan anti-mouse) are available from 
Dynal and are very convenient.  However, anti-immunoglobulin-coated 
beads can be prepared as follows: Incubate the secondary antibody (150 
µg/ml) in 0.17 M sodium tetraborate buffer (pH 9.5; 0.22 µm sterile 
filtered) with tosyl-activated Dynabeads-M450 for 24 h on a rotary stirrer 
at room temperature.  Wash the beads 4x for 10 min and then overnight 
in PBS/A+0.1% BSA on a rotary stirrer at 4oC before proceeding to coat 
them with the primary antibody as described (see Subheading 2.2.). 
Although we have found PECA-beads to be more reliable for purification 
of ECs (13) than using tosyl-activated Dynabeads directly coated with 
UEA-1 (9). 
 
6. There are now several commercial suppliers of sterile disposal cell 
strainers that provide a very convenient alternative. 
 26 
 
7. The MPC-1 magnet that we have used for many years is no longer 
manufactured, but suitable alternatives are available from Invitrogen 
Dynal AS in the DynMag range which will accept 15 ml a to 50 ml tubes.     
 
8. Omental adipose tissue obtained through general abdominal surgery can 
also be used.  However, care should be taken to remove the fat from the 
omental membranes that are covered with a layer of mesothelium prior to 
dissection. Using PECA-bead selection we have not found mesothelial 
cell contamination of MEC cultures to be a problem.  
 
9. The cell PECA-bead suspension is incubated at 4oC during the purification 
steps to minimise non-specific phagocytosis of Dynabeads. 
 
10. We do not routinely remove Dynabeads following cell selection. However, 
it may be necessary to remove the Dynabeads if you are using the cells to 
perform techniques such as flow cytometry.  CELLelection Dynabeads 
(Dynal) coated with the anti-PECAM-1 antibody can be used to select the 
MECs.  In this system antibodies are conjugated to the Dynabeads via a 
DNA linker that can be cleaved with DNase-1 to release the beads from 
the cells following selection.   
 
11. Dynabeads are internalised within ~24 h of selection and are diluted to 
negligible numbers/cell by the first passage, through cell division. 
Consistent with the original observations of Jackson and colleagues (10) 
using UEA-I-coated Dynabeads, we have not observed any adverse 
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effects on the adherence, proliferation or morphology of EC following 
PECA-bead selection (12).  
 
12. To maintain cell viability it is important to rapidly remove the endothelial 
cells from the flasks as they are very sensitive to trypsin exposure.  The 
use of a trypsin inhibitor to neutralise the tryptic activity immediately 
following detachment from the flask has been reported to prolong the 
viability of EC cultures. Mung bean trypsin inhibitor (Sigma) can be for this 
purpose, although we have not assessed its effect on endothelial viability. 
 
13. The major contaminating cell population observed in unselected adipose 
MEC cultures demonstrate a distinct fibroblastic morphology.   
 
14. The plastic wells must be removed from the multiwell chamber slides as 
the acetone will rapidly dissolve the plastic. Depending on the type used it 
may be possible to retain the gasket to make it easier to keep reagents on 
individual wells separate during the staining procedure. 
 
15. In our hands storage of the umbilical cords at 4ºC for up to 48 h after 
delivery does not appear to adversely affect the yield, or viability of 
isolated cells. 
 
16. Specialised umbilical cord scissors can be obtained cheaply from a 
number of suppliers and make the task of cutting lengths of cord a lot 
easier and safer than using scalpels. 
 
17. The luminal surface of the aorta can be simply scraped very gently to 
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remove the aortic EC. However, we have observed greater contamination 
of cultures with smooth muscle cells from the underlying intima using this 
approach compared with collagenase digestion.  Following isolation of EC 
smooth muscle cells can be explanted from the aortic segments.  
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 Figure Legends 
 
Figure 1 Photomicrograph of MEC isolated from human mammary adipose (at 
passage 2) demonstrating typical cobblestone morphology and tube formation on 
the surface of the post-confluent EC monolayer.  
 
Figure 2 Immunofluorescent staining of platelet endothelial cell adhesion 
molecule-1 (PECAM-1/CD31) in human mammary adipose MEC. 
 
Figure 3 Intense immunofluorescent staining of E-selectin (CD62E) detected in 
human mammary microvessel MEC following 6 h exposure to 10 ng/ml Tumour 
necrosis factor- α (TNFα), which is absent in unstimulated control cells (inset).  
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